Latest Launch Brings UK-Based OneWeb s Satellite Internet One Step Closer to Commercial Service – gCaptain gcaptain.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gcaptain.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The Acer Group announced that it has joined the RE100 initiative and also shared a pledge to achieve 100% renewable energy use by the year 2035..
Conversus StepStone Private Markets surpasses $100m in AUM Wednesday, May 19, 2021 Opalesque Industry Update - Conversus, an investment platform designed to expand access to the private markets for high net worth and accredited investors, announced that its inaugural fund, Conversus StepStone Private Markets (CPRIM), reached $108 mm of assets and that its shares had appreciated 36% from October 1, 2020 to April 30, 2021, to an NAV of $33.99. Conversus acts as adviser to CPRIM and is a wholly owned business of StepStone Group, which acts as sub-adviser.
CPRIM offers accredited investors diversified, global exposure to the major private market asset classes - private equity, real assets, including infrastructure and real estate, and private debt - in a single investment. An open architecture solution, CPRIM s portfolio seeks to be well-diversified across underlying managers and by sector, strategy, geography and vintage year. StepStone invests CPRIM s capital alongside its
Altasciences Acquires Calvert Laboratories Altasciences, a forward-thinking CRO/CDMO supporting all crucial steps in early-stage drug development, from lead candidate selection to clinical proof of concept, announced today that they have completed the acquisition of Calvert Laboratories, a preclinical CRO located on the U.S.A. s East Coast. This acquisition will complement Altasciences current preclinical West Coast operations, located just north of Seattle, WA. For more than 40 years, Calvert Laboratories has been working with clients to help develop the next generation of therapeutics aimed at extending and improving human life; in line with Altasciences focus on getting better drugs to the people who need them faster.